Alkem Laboratories denies claims of substandard quality for Pan-D and Clavam 625
Company asserts that reported samples are spurious and not manufactured by Alkem
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
quality standards
Passing of Biosecure Act a positive development
Jonathan Hunt MD and CEO, Syngene International analyses that though the change in the Biosecure Act around the timeline of…